ArticleFuture oncology (London, England)2024

Patterns and outcomes in HR+/HER2- advanced/metastatic breast cancer patients in Brazil receiving palbociclib.

Patricia Simon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.